三友医疗跌2.03%，成交额1741.90万元，主力资金净流出218.97万元

Core Viewpoint - Sanyou Medical's stock has experienced fluctuations, with a year-to-date increase of 22.97% but a recent decline of 8.97% over the past five trading days [1] Group 1: Stock Performance - As of September 9, Sanyou Medical's stock price was 21.71 CNY per share, with a market capitalization of 7.239 billion CNY [1] - The stock has seen a trading volume of 17.419 million CNY and a turnover rate of 0.27% [1] - The stock's performance over various periods includes a 2.16% increase over the last 20 days and a 39.57% increase over the last 60 days [1] Group 2: Financial Performance - For the first half of 2025, Sanyou Medical reported a revenue of 250 million CNY, representing a year-on-year growth of 17.77% [2] - The net profit attributable to shareholders for the same period was 36.6008 million CNY, showing a significant year-on-year increase of 2083.64% [2] Group 3: Shareholder Information - As of June 30, 2025, the number of shareholders for Sanyou Medical was 7,108, an increase of 12.61% from the previous period [2] - The average number of circulating shares per shareholder decreased by 11.20% to 34,954 shares [2] - Cumulative cash dividends since the company's A-share listing amount to 113 million CNY, with 39.7452 million CNY distributed over the last three years [3] Group 4: Company Overview - Sanyou Medical, established on April 19, 2005, specializes in the research, development, production, and sales of orthopedic implants and ultrasonic power devices and consumables [1] - The company's main revenue sources include spinal implant consumables (63.80%), active devices and supporting accessories (31.51%), trauma implant consumables (3.53%), and others (1.16%) [1] - The company is categorized under the pharmaceutical and biological industry, specifically in medical devices and consumables [1]